Your browser doesn't support javascript.
loading
B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study.
Tashireva, Liubov A; Popova, Nataliya O; Kalinchuk, Anna Yu; Goldberg, Viktor E; Kovalenko, Elena I; Artamonova, Elena V; Manikhas, Aleksey G; Ponomarenko, Dmitriy M; Levchenko, Nataliya V; Rossokha, Elena I; Krasilnikova, Svetlana Yu; Zafirova, Marina A; Choynzonov, Evgeniy L; Perelmuter, Vladimir M.
Afiliação
  • Tashireva LA; Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • Popova NO; Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • Kalinchuk AY; Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • Goldberg VE; Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • Kovalenko EI; Federal State Budgetary Institution National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow, Russia.
  • Artamonova EV; Federal State Budgetary Institution National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation (NN Blokhin NMRCO), Moscow, Russia.
  • Manikhas AG; Saint-Petersburg State Budgetary Healthcare Institution "City Clinical Oncology Center" (1st Oncology (Surgery) Department, Saint-Petersburg, Russia.
  • Ponomarenko DM; Chemotherapy Department, Irkutsk Regional Cancer Center, Irkutsk, Russia.
  • Levchenko NV; Department of Oncology, Irkutsk State Medical Academy of Postgraduate Education, Irkutsk, Russia.
  • Rossokha EI; Chemotherapy Department, State Budgetary Healthcare Institution "St. Petersburg Clinical Scientific and Practical Center of Specialized Types of Medical Care (Oncological)", St. Petersburg, Russia.
  • Krasilnikova SY; Chemotherapy Department, Regional State Budgetary Healthcare Institution "Altai Regional Oncology Center", Barnaul, Russia.
  • Zafirova MA; Chemotherapy Department, Sverdlovsk Regional Oncological Dispensary, Ekaterinburg, Russia.
  • Choynzonov EL; Federal State Budget Educational Institution of Higher Education, Ural State Medical University of the Ministry of Health of the Russian Federation, Ekaterinburg, Russia.
  • Perelmuter VM; Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Front Oncol ; 12: 909505, 2022.
Article em En | MEDLINE | ID: mdl-35814376
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article